Pharmacare diabetes drugs: what four jurisdictions cover

If you live with diabetes, what you pay at the pharmacy counter depends heavily on where you live. Under national pharmacare agreements with the federal government, four jurisdictions now cover a range of diabetes medications at little or no cost: British Columbia, Manitoba, Prince Edward Island and Yukon. But the details differ, especially for devices and supplies such as test strips and glucose monitors.

Health Canada says the agreements make “a range of contraception and diabetes medications free” at the pharmacy counter for residents of participating provinces and territories. The federal government lists metformin, insulin, sulfonylureas and SGLT-2 inhibitors among the diabetes medications generally covered. Items used to give medication, such as insulin pumps and syringes, and items used to monitor the condition, such as glucose monitors and test strips, are part of the broader federal framework. How much of that each jurisdiction has rolled out is a separate question.

Health Canada also notes that you may still pay other fees, such as prescribing or delivery fees. And if you choose a brand-name drug when a cheaper equivalent exists, most programs ask you to pay the difference.

Quick comparison

British Columbia

B.C.’s Plan NP launched on March 1, 2026. The B.C. government says insulins, metformin, glyburide, gliclazide, dapagliflozin, empagliflozin and empagliflozin with metformin are covered at 100 per cent. A second group, including linagliptin, pioglitazone and saxagliptin, requires Special Authority, which means your prescriber must submit a request and have it approved before you fill the prescription.

You must be a B.C. resident enrolled in the Medical Services Plan, and the prescription must be filled in B.C. Show your prescription and your BC Services Card at the pharmacy. Insulins do not need a prescription. There is no registration, and no receipts to submit. The province says coverage of certain diabetes supplies and devices expanded on April 1, 2026, with federal funding, and points readers to its diabetes management page for the list.

Manitoba

The Manitoba Enhanced Pharmacare Program took effect on April 15, 2025. Most diabetes medications are covered at no cost, though Ozempic (semaglutide) is not included. Diabetes supplies are not part of this program. They stay under the regular Manitoba Pharmacare Program, where deductibles apply. Manitoba separately runs an adult insulin pump program for people 18 and older who meet its criteria, and continuous and flash glucose monitors are Manitoba Pharmacare benefits for eligible clients.

You need an active Manitoba Health card. You are not eligible if another federal or provincial program already pays 100 per cent of your drug costs, such as Non-Insured Health Benefits. Private insurance does not disqualify you. The program also pays a pharmacy professional fee of up to $14, limited to one fee per month for diabetes medications. Most pharmacies can dispense up to a 100-day supply.

Prince Edward Island

P.E.I.’s national pharmacare program began on May 1, 2025, and is not retroactive. To qualify, you must be a P.E.I. resident with a valid Health Card and take a drug on the National Pharmacare list. The province lists a range of insulins, along with oral drugs such as metformin (immediate-release only), glyburide, gliclazide and dapagliflozin. Some products need special authorization.

No application is needed for medications. Fill your prescription at a community retail pharmacy in P.E.I.; out-of-province pharmacies are not eligible. Blood glucose test strips are the only diabetes supply listed, and they require enrolment in the P.E.I. Pharmacare Diabetes Drug Program. Strips cost $11 per prescription of 100, with annual limits that depend on the medications you take. For program questions, call PEI Pharmacare at 902-368-4947 or 1-877-577-3737.

Yukon

Yukon’s program launched on April 15, 2026. Eligible residents are enrolled automatically, with no application. You need valid Yukon Health Care Insurance Plan coverage, and you cannot be covered by certain federal programs, including Non-Insured Health Benefits, the Canadian Armed Forces Drug Benefit Plan and Veterans Affairs Canada Treatment Benefits.

Covered drugs are those on the Yukon Drug Formulary, free apart from any brand-name price difference under the Lower-Cost Alternative policy. The territory also lists newer insulin pump technology, such as the Omnipod 5 system that works with Dexcom G6 and G7 sensors. Pump eligibility is granted every five years. Yukon says GLP-1 drugs such as Ozempic, and diabetes equipment, supplies and glucose monitoring devices, are not covered under this program and points those to its Chronic Disease and Disability Benefits Program (867-667-5092) or the Senior Pharmacare Program (867-667-5403). Supplies are limited to 100 days at a time, with refills once 66 per cent has been used.

What about everywhere else?

Health Canada’s list of national pharmacare bilateral agreements names only these four jurisdictions at the time of writing. Other provinces and territories have their own existing drug plans, some with diabetes supplies programs, but those are separate from the federal agreements. If you live elsewhere, your provincial or territorial drug benefit page and your pharmacist are the best places to check current coverage. Residents with coverage through federal programs or workplace plans should also ask how those interact with public plans.

A practical tip from all four programs: ask your pharmacist whether a fully covered generic is available for your medication. In several of these jurisdictions, choosing the brand name can leave you paying the difference.

Sources: Health Canada: About national pharmacare; Health Canada: National pharmacare bilateral agreements; Government of B.C.: National pharmacare; Government of Manitoba: Manitoba Enhanced Pharmacare Program; Government of P.E.I.: National Pharmacare Program; Government of Yukon: National Pharmacare Program.

This article is based on official guidance from Health Canada and the governments of British Columbia, Manitoba, Prince Edward Island and Yukon, and is provided for general public information. It’s not a substitute for medical advice, if you have questions about how this applies to you, talk to your doctor or pharmacist.

If you find reporting like this useful, consider supporting Canada News Media, an independent Canadian newsroom with no corporate parent.